Roxanne Meyer

822 total citations
31 papers, 651 citations indexed

About

Roxanne Meyer is a scholar working on Molecular Biology, Infectious Diseases and Rheumatology. According to data from OpenAlex, Roxanne Meyer has authored 31 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Rheumatology. Recurrent topics in Roxanne Meyer's work include Rheumatoid Arthritis Research and Therapies (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Legionella and Acanthamoeba research (5 papers). Roxanne Meyer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Legionella and Acanthamoeba research (5 papers). Roxanne Meyer collaborates with scholars based in United States, Belgium and Italy. Roxanne Meyer's co-authors include Paul H. Edelstein, S M Finegold, Samir H. Mody, Tiffany P. Quock, Anisha M. Patel, Roger M. McKinney, M A Edelstein, Joseph Tkacz, Charles Ruetsch and Lajos Pikó and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Roxanne Meyer

31 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxanne Meyer United States 12 248 174 139 115 83 31 651
Petra Schelstraete Belgium 18 134 0.5× 178 1.0× 56 0.4× 174 1.5× 139 1.7× 53 809
Richard H. Savel United States 15 172 0.7× 359 2.1× 46 0.3× 94 0.8× 46 0.6× 46 1.1k
Hea Won Ann South Korea 14 84 0.3× 55 0.3× 58 0.4× 169 1.5× 92 1.1× 25 585
Nachiket Patel United States 10 57 0.2× 197 1.1× 37 0.3× 52 0.5× 47 0.6× 32 512
A. Rekha Murthy United States 12 116 0.5× 254 1.5× 32 0.2× 271 2.4× 256 3.1× 26 973
Te‐Yu Lin Taiwan 17 51 0.2× 107 0.6× 79 0.6× 252 2.2× 249 3.0× 65 751
David L. Dworzack United States 13 58 0.2× 36 0.2× 69 0.5× 190 1.7× 104 1.3× 23 462
In Young Jung South Korea 15 71 0.3× 67 0.4× 64 0.5× 192 1.7× 197 2.4× 44 615
Jack A. Barnett United States 9 69 0.3× 36 0.2× 52 0.4× 133 1.2× 66 0.8× 15 412
J Wedgwood Switzerland 12 32 0.1× 94 0.5× 72 0.5× 361 3.1× 69 0.8× 13 766

Countries citing papers authored by Roxanne Meyer

Since Specialization
Citations

This map shows the geographic impact of Roxanne Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne Meyer more than expected).

Fields of papers citing papers by Roxanne Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxanne Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne Meyer. The network helps show where Roxanne Meyer may publish in the future.

Co-authorship network of co-authors of Roxanne Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Roxanne Meyer. A scholar is included among the top collaborators of Roxanne Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxanne Meyer. Roxanne Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levidou, Georgia, et al.. (2024). Clinical Significance of the Immunohistochemical Expression of Histone Deacetylases (HDACs)-2, -4, and -5 in Ovarian Adenocarcinomas. Biomedicines. 12(5). 947–947. 1 indexed citations
2.
Tkacz, Joseph, et al.. (2016). Assessment of Rheumatoid Arthritis Quality Process Measures and Associated Costs. Population Health Management. 20(1). 31–40. 5 indexed citations
3.
Tkacz, Joseph, et al.. (2015). Prescribing Patterns of Intravenous Golimumab for Rheumatoid Arthritis. Clinical Therapeutics. 37(9). 2028–2036. 4 indexed citations
4.
Tkacz, Joseph, et al.. (2015). An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease. Journal of Managed Care & Specialty Pharmacy. 21(11). 1064–1076. 10 indexed citations
5.
Tkacz, Joseph, et al.. (2015). Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis.. PubMed. 8(9). 494–505. 4 indexed citations
6.
Tkacz, Joseph, et al.. (2015). Quality Process Measures for Rheumatoid Arthritis: Performance from Members Enrolled in a National Health Plan. Journal of Managed Care & Specialty Pharmacy. 21(2). 135–143. 3 indexed citations
8.
Meyer, Roxanne, et al.. (2014). Prescription Opioid Abuse: A Literature Review of the Clinical and Economic Burden in the United States. Population Health Management. 17(6). 372–387. 153 indexed citations
9.
Tkacz, Joseph, et al.. (2014). Utilization and Adherence Patterns of Subcutaneously Administered Anti–Tumor Necrosis Factor Treatment Among Rheumatoid Arthritis Patients. Clinical Therapeutics. 36(5). 737–747. 40 indexed citations
10.
Meyer, Roxanne, et al.. (2001). Comparison of Antimicrobial Use and Resistance of Bacterial Isolates in a Haematology Ward and an Intensive Care Unit. European Journal of Clinical Microbiology & Infectious Diseases. 20(9). 657–660. 12 indexed citations
11.
Meyer, Roxanne, et al.. (2001). Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.. PubMed. 24(1). 47–56. 3 indexed citations
12.
Leo, Yee‐Sin, et al.. (1994). Bronchiolitis Obliterans Organizing Pneumonia in a Patient with AIDS. Clinical Infectious Diseases. 18(6). 921–924. 18 indexed citations
13.
Mathisen, Glenn E., et al.. (1993). Pneumonia, Aseptic Meningitis, and Leukopenia in a 28-Year-Old Man. Clinical Infectious Diseases. 16(6). 809–815. 5 indexed citations
14.
Mathisen, Glenn E., et al.. (1992). Pulmonary Infiltrate and Pleural Effusion in a Diabetic Man. Clinical Infectious Diseases. 14(4). 955–960. 2 indexed citations
15.
Mathisen, Glenn E., et al.. (1992). Pyelonephritis, Rash, and Progressive Respiratory Failure in a Pregnant Woman. Clinical Infectious Diseases. 14(2). 599–607. 1 indexed citations
16.
Mathisen, Glenn E., Roxanne Meyer, Michael Lovett, E. J. C. Goldstein, & Jacob Fleischmann. (1992). Fever in a Couple Vacationing in the Mountains of Southern California. Clinical Infectious Diseases. 14(6). 1254–1258. 2 indexed citations
17.
Mathisen, Glenn E., et al.. (1992). Transfusion-Dependent Anemia in a Patient with AIDS. Clinical Infectious Diseases. 15(3). 533–539. 8 indexed citations
18.
Meyer, Roxanne, Tarsem Moudgil, Roger Detels, et al.. (1990). Seroprevalence of Human T Cell Leukemia Viruses in Selected Populations of Homosexual Men. The Journal of Infectious Diseases. 162(6). 1370–1372. 6 indexed citations
19.
Edelstein, Paul H., et al.. (1982). Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms. Antimicrobial Agents and Chemotherapy. 22(1). 90–93. 14 indexed citations
20.
Pikó, Lajos, et al.. (1978). Structural and replicative forms of mitochondrial DNA from human leukocytes in relation to age. Mechanisms of Ageing and Development. 7(5). 351–365. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026